Purple biotech provides corporate update and reports first half 2021 financial results

Rehovot, israel, aug. 05, 2021 (globe newswire) -- purple biotech ltd. (“purple biotech”, or the “company”) (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today provided a corporate update and announced financial results for the six months ended june 30, 2021.
PPBT Ratings Summary
PPBT Quant Ranking